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Abstract 
Background: Severe falciparum malaria can be compounded by bacterial sepsis, necessitating antibiotics in addition 
to anti-malarial treatment. The objective of this analysis was to develop a prognostic model to identify patients admit-
ted with severe malaria at higher risk of developing bacterial sepsis.
Methods: A retrospective data analysis using trial data from the South East Asian Quinine Artesunate Malaria Trial. 
Variables correlating with development of clinically defined sepsis were identified by univariable analysis, and sub-
sequently included into a multivariable logistic regression model. Internal validation was performed by bootstrap-
ping. Discrimination and goodness-of-fit were assessed using the area under the curve (AUC) and a calibration plot, 
respectively.
Results: Of the 1187 adults with severe malaria, 86 (7.3%) developed clinical sepsis during admission. Predictors for 
developing sepsis were: female sex, high blood urea nitrogen, high plasma anion gap, respiratory distress, shock on 
admission, high parasitaemia, coma and jaundice. The AUC of the model was 0.789, signifying modest differentiation 
for identifying patients developing sepsis. The model was well-calibrated (Hosmer–Lemeshow Chi squared = 1.02). 
The 25th percentile of the distribution of risk scores among those who developed sepsis could identify a high-risk 
group with a sensitivity and specificity of 70.0 and 69.4%, respectively.
Conclusions: The proposed model identifies patients with severe malaria at risk of developing clinical sepsis, poten-
tially benefiting from antibiotic treatment in addition to anti-malarials. The model will need further evaluation with 
more strictly defined bacterial sepsis as outcome measure.
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Background
In the past decade, significant gains have been made in 
the global control of malaria with a decreased malaria 
incidence of 37.7% worldwide from 146 per 1000 to 
91 per 1000 population [1, 2], and a 62% decrease in 
malaria-associated mortality in 2015 compared to 2000 
[1–3]. However, malaria is still responsible for half a 
million deaths annually and the case fatality of severe 
malaria remains high. Patients with severe malaria are at 
increased risk of developing concomitant bacterial sep-
sis, which increases the risk of a fatal outcome. Recent 
studies in sub-Saharan Africa showed that 4–23% of chil-
dren with severe malaria had concomitant sepsis [4–7]. 
In adult severe malaria, bacterial sepsis is less common 
but still considerable, with a reported incidence of 13% in 
Myanmar [8].
Although hypotension is much less common in severe 
malaria compared to bacterial sepsis [9], other clinical 
features of severe malaria and severe sepsis with organ 
failure overlap, hampering the diagnosis of concomi-
tant sepsis. Blood cultures to diagnose invasive bacte-
rial infections are rarely available in resource-limited 
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settings, which comprises most of the malaria endemic 
countries [10]. In paediatric severe malaria, where con-
comitant bacterial sepsis is common, treatment guide-
lines recommend routine co-administration of antibiotics 
to anti-malarial treatment [11, 12]. Routine antibiotics it 
not recommended for adult patients with severe malaria. 
In this group it is important to identify patients at risk for 
concomitant bacterial sepsis, since these would require 
life-saving antibiotic treatment in addition to anti-
malarial treatment. Antibiotics can then be withheld in 
patients identified at low risk for bacterial sepsis, saving 
costs and reducing antibiotic drug pressure driving anti-
microbial drug resistance [13].
This analysis, therefore, aims to develop a prognostic 
model to identify adult patients with severe falciparum 
malaria at greater risk of developing sepsis using data 
from a large malaria treatment study.
Methods
Study design, study population and sampling
The study was a retrospective analysis of the South 
East Asian Quinine Artesunate Malaria Trial (SEAQ-
UAMAT), a large randomized controlled trial (RCT) 
comparing intravenous artesunate with quinine as anti-
malarial treatment. The SEAQUAMAT study was carried 
out from June 2003 to May 2005 in 10 healthcare facilities 
in four Southeast Asian countries: Bangladesh (n = 1), 
India (n = 1), Indonesia (n = 1) and Myanmar (n = 7). The 
study randomized 1461 patients with severe malaria into 
two arms, with 730 patients receiving artesunate and 731 
patients receiving quinine. Inclusion and exclusion crite-
ria, study procedures, and definitions for severe malaria 
have previously been published [14]. In addition, children 
(age ≤ 16 years, n = 274) were excluded from the present 
study. The main study outcome was in-hospital mortality 
from severe malaria. The study showed that in-hospital 
mortality was reduced by 34.7% in patients who received 
intravenous artesunate when compared to patients who 
received quinine arm [14]. Secondary outcomes included 
incidence of neurological sequelae and development of 
sepsis.
Definitions of parameters
Coma: Glasgow coma scale < 11/15 in adults.
Clinical shock: Based on clinical judgement of 
admitting physician taking into consideration a low 
BP (< 80/60 mmHg) and cold extremities.
Respiratory distress: Respiratory rate > 32 breaths 
per minute.
Hyperparasitaemia: Asexual Plasmodium falcipa-
rum parasitaemia > 10%.
Severe anaemia: Haemoglobin < 5.0 g/dl.
Hypoglycaemia: Plasma glucose < 2.2 mmol/l.
Acidosis: Blood bicarbonate < 15  mmol/l or base 
excess < 3.3 mmol/l.
Acute kidney injury: Blood urea nitrogen > 20 mg/dl.
Sepsis: The clinical diagnosis of sepsis was made by 
the attending physician based mainly on the devel-
opment of shock (hypotension with cold extremi-
ties) as laboratory assessments such as full blood 
counts were not routinely available, and blood cul-
tures were not performed.
Statistical analysis
Means (standard deviations) or medians (interquartile 
range) were used to summarize continuous variables as 
appropriate while proportions and frequencies were used 
to summarize categorical variables. Variables potentially 
related with the development of sepsis were selected 
based on their association described in published lit-
erature and included: age; gender; presence of coma on 
admission; convulsions; prostration; shock (clinical shock 
and blood pressure); anaemia (haemoglobin and haema-
tocrit levels); acute kidney injury [blood urea nitrogen 
(BUN) and serum potassium levels]; presence of jaun-
dice; glycaemia levels; temperature; acidosis (Venous pH, 
base excess, total  CO2, anion gap); parasite count and 
respiratory distress (respiratory rate and clinical respira-
tory distress).
A univariable logistic regression analysis was per-
formed with sepsis as the outcome and all the potential 
predictors for development of sepsis in severe malaria. 
All variables with p values < 0.05 were included in the 
multivariable logistic regression analysis model. Subse-
quently, a bootstrap analysis with 5000 simulations was 
performed to compare the measures of effect obtained 
from the original model with the bootstrapped model. 
Variables which remained significant were then used to 
produce a nomogram.
Discrimination of the model was assessed by calculat-
ing the AUC of the ROC curve. Bootstrapping was done 
with 5000 simulations to obtain a bootstrapped AUC. 
This bootstrapped AUC was compared with the original 
AUC. The discriminative properties using the AUC were 
assessed using the following classification: 0.90–1 excel-
lent; 0.80–0.90—good; 0.70–0.80—fair; 0.60–0.70—poor 
and 0.50–0.60—very poor discriminative properties [15]. 
Discrimination was further assessed using the Brier score 
and the Somers’ D coefficient. The Somers’ D obtained 
for the original model was compared to that obtained 
from applying the models from the bootstrapped data-
sets to the original dataset. An estimate of optimism was 
calculated as the difference between the two coefficients 
[16]. The optimism corrected estimate of the Somers’ D 
was then calculated and converted to a c-statistic to have 
an interpretation similar to the AUC.
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Calibration was assessed by drawing a calibration plot 
after dividing the data into ten risk groups.
The predictors were then divided into categories with 
each category assigned a numerical value depending on 
the contribution of the predictor towards the probabil-
ity of developing sepsis. For each patient, the numeri-
cal score of each predictor was added to produce a total 
score. The 25th percentile of the distribution of total 
scores among those with sepsis was used to classify 
patients at high risk of developing sepsis and respective 
sensitivity and specificity calculated.
A nomogram based on the numerical contributions 
of each of the predictors in the model was constructed 
from the logistic regression model. The data were ana-
lysed using the R statistical software package (R Founda-
tion for Statistical Computing, Vienna, Austria) and Stata 
software package version 12 (Statacorp, College Station, 
TX, USA).
Ethical considerations
The SEQUAMAT study received ethical clearance from 
OXTREC, the national ethical committees of the coun-
tries involved and from the ethical institutions of the 
four countries where the trial was conducted. Ethics 
and administrative approval was obtained from MORU 
(Mahidol-Oxford Tropical Research Unit) to use the data 
for this secondary data analysis. The analysis used de-
identified data from the curated SEAQUAMAT database, 
which did not include patient names. Anonymized iden-
tification numbers were used.
Results
A total of 1187 adults (age > 16  years) were included in 
the SEAQUAMAT trial and 899 (75.7%) were males. The 
ages ranged from 17 to 87 years with a median age of 28 
(Interquartile range 22–40). More than half (52.6%) of 
the patients had jaundice on admission while 11.5% pre-
sented with shock (Table 1). A total of 86 (7.3%, 95% CI 
5.8, 8.7) patients developed sepsis after admission. Indo-
nesia had the highest proportion (19.2%) of patients who 
developed sepsis while Myanmar had the lowest (3.7%) 
(Table 1) (Additional file 1). Patients who developed sep-
sis were over three times more likely to die during admis-
sion than those who did not (OR: 3.48; 95% CI 2.15, 5.60; 
p value < 0.001).
Model development
On univariable analysis, the following predictors were 
associated with development of sepsis: female sex (OR: 
2.70; 95% CI 1.72, 4.22), jaundice on admission (OR: 1.85, 
95% CI 1.17, 2.94), a high anion gap (OR: 1.04, 95% CI 
1.01, 1.06), a high parasite count (OR: 1.04, 95% CI 1.02, 
1.06), high blood urea nitrogen levels (OR: 1.01, 95% 
CI 1.01, 1.02), high respiratory rates on admission (OR: 
1.03, 95% CI 1.01, 1.05), shock on admission (OR: 2.74, 
95% CI 1.62, 4.65) and respiratory distress on admission 
(OR: 3.14, 95% CI 1.82, 5.39.74) (Table 2). Those who had 
lower mean arterial blood pressures (OR: 0.98, 95% CI 
0.96, 0.99) and a low base excess (OR: 0.94, 95% CI 0.92, 
0.97) were also more likely to develop sepsis (Table 2).
On multivariable analysis after forward selection of 
variables, female sex (aOR: 2.36, 95% CI 1.34, 4.17), high 
blood urea nitrogen levels (aOR: 1.01, 95% CI 1.00, 1.02), 
high anion gap (aOR: 1.02, 95% CI 1.00, 1.05), high per-
centage parasitaemia (aOR: 1.03, 95% CI 1.01, 1.06), vis-
ible jaundice on admission (aOR: 1.78, 95% CI 1.03, 3.07), 
shock on admission (aOR: 2.85, 95% CI 1.35, 5.99), coma 
on admission (aOR: 2.17, 95% CI 1.21, 3.90) and respira-
tory distress on admission (aOR: 3.62, 95% CI 1.69, 7.76) 
remained statistically significant (Table 3). Results of the 
5000 simulations by bootstrapping had the same meas-
ures of effect to those obtained by the logistic regression 
model (Table 3).
Model validation
The AUC based on the logistic regression model was 0.78 
(95% CI 0.72, 0.83) (Fig.  1). After 5000 simulations, the 
bootstrapped area under the curve was 0.78 (95% CI 0.72, 
0.83). The Brier score obtained from the model was 0.06 
(95% CI 0.05–0.07, p < 0.001). The optimism corrected 
estimate of the Somers’ D was 0.48 (Table 3) with a cor-
responding c-statistic of 0.74.
The participants were divided into ten groups based 
on the probability of developing sepsis. There was no 
difference between the observed values for patients who 
developed sepsis after admission for severe malaria with 
the values predicted by the model (Fig. 2, Hosmer–Leme-
show Chi squared statistic = 1.02, p = 0.995).
The predictors from the final model were arranged into 
categories with each category assigned a numerical value 
depending on its contribution to the development of sep-
sis (Table 4). The median, 25th and 75th percentile of the 
total score for those who developed sepsis were 18.8, 14.6 
and 23.2 respectively. The median, 25th and 75th percen-
tile of the total score for those who did not develop sepsis 
were 12.8, 9.9 and 16.5 respectively. The diagnostic prop-
erties of the model at cut-offs of the median, 25th and 
75th percentile of the total score for those who developed 
sepsis were calculated (Table  5). A nomogram obtained 
from the above predictive variables is shown in Fig. 3.
Discussion
This study showed that the prevalence of patients who 
developed clinical sepsis after admission for severe 
malaria in Southeast Asia was 7.3%. It should be noted 
that severe sepsis in this study was defined clinically, 
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mainly based on the development of shock (hypotension 
with cold extremities). Laboratory assessments such as 
full blood counts were not routinely available, and blood 
cultures were not performed. It is likely that the true inci-
dence of bacterial sepsis complicating severe malaria was 
underestimated in this dataset. Indeed, the incidence of 
sepsis in this study was lower than the 13% incidence 
reported in a study from Myanmar in adult patients with 
severe malaria using blood culture results as an outcome 
measure [8].
In the current study, patients with malaria who devel-
oped clinical sepsis upon admission were three times 
more likely to die than patients who were admitted 
for severe malaria only. The increase in case fatality in 
patients with concomitant sepsis has also been described 
in African children with severe malaria. For instance, 
a study amongst 1780 children admitted with slide 
confirmed severe malaria in Mozambique showed that 
the case fatality rate rose from 4.0 to 22% in the pres-
ence of bacteraemia [12, 17]. Current WHO guidelines 
therefore recommend the co-administration of paren-
teral broad spectrum antibiotics in addition to parenteral 
artesunate for the treatment of severe malaria in chil-
dren [11]. For adult patients with severe malaria routine 
antibiotics are not recommended, because of the lower 
incidence of concomitant bacterial sepsis. Identification 
of patients at risk of sepsis is thus important, since these 
patients will benefit from antibiotic treatment.
This model identified independent predictors for devel-
opment of sepsis in severe malaria including female 
sex, coma on admission, respiratory distress on admis-
sion, high anion gap (acidosis), high parasitaemia, high 
BUN levels, shock on admission and visible jaundice on 
admission. All these predictors are clinical symptoms 
Table 1 Baseline characteristics for patients admitted for severe malaria
Hb haemoglobin, BUN blood urea nitrogen, RBC red blood cells, mmol/l millimoles per litre, g/dl grams per decilitre, mg/dl milligrams per decilitre
Characteristic Category N % Artesunate 
arm
Quinine arm Sepsis 
development
n (%) n (%) n (%)
1 Country Myanmar 458 38.6 233 50.9 225 49.1 17 3.7
Bangladesh 399 33.6 198 49.6 201 50.4 21 5.3
India 137 11.4 67 48.9 70 51.1 11 8.0
Indonesia 193 16.3 97 50.3 96 49.7 37 19.2
2 Sex Male 899 75.7 456 50.7 443 49.3 48 5.3
Female 288 24.3 139 48.3 149 51.7 38 13.2
3 Age 17–25 504 43.6 249 49.4 255 50.6 33 6.6
26–35 321 22.2 167 52.0 154 48.0 26 8.1
36–45 188 13.0 96 51.1 92 48.9 18 9.6
46–87 174 12.1 83 47.7 91 52.3 9 5.2
4 Respiratory distress Yes 117 9.9 51 43.6 66 56.4 20 17.1
No 1070 90.1 544 50.8 526 49.2 66 6.2
5 Coma on admission Yes 505 42.5 255 50.5 250 49.5 46 9.1
No 682 57.5 340 49.9 342 50.2 40 5.9
6 Hypoglycaemia on admission (blood glu-
cose < 2.2 mmol/l)
Yes 19 1.7 8 42.1 11 57.9 1 5.3
No 1127 98.3 568 50.4 559 49.6 85 7.5
7 Shock on admission Yes 137 11.5 65 47.5 72 52.6 21 15.3
No 1050 88.5 530 50.5 520 49.5 65 6.2
8 Jaundice on admission Yes 624 52.6 319 51.1 305 48.9 57 9.1
No 563 47.4 276 49.0 287 51.0 29 5.2
9 Severe anaemia on admission (Hb < 5.0 g/dl) Yes 60 5.0 31 51.7 29 48.3 11 18.3
No 1127 95.0 564 50.0 563 50.0 75 6.7
10 Acute kidney injury (BUN > 20 mg/dl) Yes 277 24.6 130 46.9 147 53.1 37 13.4
No 850 75.4 440 51.8 410 48.2 45 5.3
11 Acidosis on admission (base excess < 3.3 mmol/l) Yes 524 48.7 254 48.5 270 51.5 59 11.3
No 551 51.3 289 52.5 262 47.5 23 4.2
12 Hyperparasitaemia on admission (> 10% RBCs infected) Yes 185 15.6 99 53.5 86 46.5 26 14.1
No 1002 84.4 496 49.5 506 50.5 60 6.0
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or laboratory parameters associated with both bacterial 
sepsis and severe malaria, except for patient gender. The 
finding that female patients were two times more likely 
to have concomitant sepsis than male patients was unex-
pected and unexplained. The finding is consistent with 
a Kenyan study on paediatric severe malaria, which also 
showed that bacteraemia occurred in significantly higher 
proportions in females than in males [18]. Coma is not a 
common finding in severe sepsis, unless there is severe 
septic shock or meningo-encephalitis as the source of 
Table 2 Univariable analysis of predictors for the development of sepsis in patients admitted for severe malaria
BCS Blantyre coma score, GCS Glasgow coma score, BP blood pressure, MAP mean arterial blood pressure, OR odds ratio, CI confidence interval, BUN blood urea 
nitrogen, mm/Hg millimetres of mercury, mmol/l millimoles per litre, g/dl grams per decilitre, mg/dl milligrams per decilitre, °C degrees centigrade; μl microlitre, min 
minute
a Significant variables on univariate analysis
b Variables omitted from logistic regression model due to multicollinearity
Characteristic Category N OR 95% CI p value
1 Age Age (years) 1187 1.00 0.98, 1.01 0.749
2 Sex Sexa
 Female 288 0.37 0.24, 0.58 < 0.001
 Male 899 1.00
3 Cerebral malaria Coma (GCS < 11 or BCS < 3)
 Yes 476 1.47 0.95, 2.28 0.088
 No 711 1.00
Convulsions
 Yes 113 1.28 0.64, 2.54 0.490
 No 1074 1.00
Prostrationa
 Yes 435 0.61 0.37, 0.99 0.050
 No 752 1.00
4 Haemodynamic shock Systolic BP (mm/Hg)a,b 1177 0.98 0.97, 0.99 0.001
Diastolic BP (mm/Hg)a,b 1176 0.98 0.96, 0.99 0.002
MAP (mm/Hg) 1176 0.98 0.96, 0.99 0.001
Clinical  shocka
 Yes 137 2.74 1.62, 4.65 < 0.001
 No 1050 1.00
5 Severe anaemia Haemoglobin (g/dl)a 1112 0.94 0.87, 1.00 0.052
Haematocrit (%) 1100 0.98 0.96, 1.00 0.080
6 Renal failure BUN level (mg/dl)a 1127 1.01 1.01, 1.01 < 0.001
Serum potassium (mg/dl) 1076 1.23 0.94, 1.61 0.161
7 Jaundice Jaundicea
 Yes 624 1.85 1.17, 2.94 0.009
 No 563 1.00
8 Hypoglycaemia Glycaemia (mg/dl) 1146 1.00 0.99, 1.00 0.438
9 Hyperpyrexia Temperature (°C) 1185 0.96 0.79, 1.16 0.655
10 Acidosis Venous  pHa,b 1068 0.09 0.02, 0.40 0.002
Base excess (mmol/l)a 1075 0.94 0.92, 0.97 <0.001
Total CO2
a,b 1071 0.92 0.89, 0.96 < 0.001
Anion gap (mmol/l)a 1050 1.04 1.01, 1.06 0.002
11 Hyperparasitaemia Parasite count (/μl)a 1187 2.57 1.57, 4.19 < 0.001
Percentage parasitaemia (%)a,b 1187 1.04 1.02, 1.06 < 0.001
12 Respiratory distress Respiratory rate (cycles/min)a 1185 1.02 1.01, 1.05 0.003
Respiratory  distressa
 Yes 117 3.14 1.82, 5.39 < 0.001
 No 1070 1.00
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sepsis. However, presence of coma predisposes for aspi-
ration pneumonia, which can develop into sepsis.
Respiratory distress could result from acute respira-
tory distress syndrome (ARDS), metabolic acidosis, fluid 
overload, aspiration pneumonia or other concomitant 
diseases [19]. ARDS is a common complication of both 
sepsis and severe malaria. However, ARDS is more com-
mon in bacterial sepsis [18], which could partly explain 
its prognostic significance for sepsis in this study. Devel-
opment of hospital-acquired pneumonia could contrib-
ute further to the development sepsis during admission 
[19]. Study findings are in line with a Kenyan study 
Table 3 Multivariable logistic regression and  bootstrap analysis for  predictors for  development of  sepsis in  patients 
admitted for severe malaria
aOR adjusted odds ratio, CI confidence interval, BUN blood urea nitrogen, BOR bootstrapped odds ratio, B bootstrapped, mmol/l millimoles per litre, mg/dl milligrams 
per decilitre
* Variables significant on multivariable analysis
a Estimate of optimism = 0.03
b Included in final regression model
Predictors Category aOR 95% CI p value BOR B 95% CI B p value
Sex*,b Female 2.36 1.34, 4.17 0.003 2.36 1.30, 4.29 0.005
Male 1.00 1.00
Coma on  admissionb Yes 2.17 1.21, 3.90 0.010 2.17 1.19, 3.93 0.011
No 1.00 1.00
Prostration on admission Yes 1.00 0.55, 1.84 0.989 1.00 0.55, 1.84 0.989
No 1.00 1.00
Mean arterial pressure (mmHg) 0.99 0.97, 1.01 0.325 0.99 0.97, 1.01 0.308
Shock on  admissionb Yes 2.85 1.35, 5.99 0.006 2.85 1.29, 6.28 0.009
No 1.00 1.00
Haemoglobin on admission (mg/dl) 0.98 0.90, 1.07 0.646 0.98 0.89, 1.08 0.687
BUN (mg/dl)*,b 1.01 1.00, 1.02 0.004 1.01 1.00, 1.02 0.005
Visible jaundice on  admissionb Yes 1.78 1.03, 3.07 0.038 1.78 1.02, 3.10 0.042
No 1.00 1.00
Base excess on admission (mmol/l) 1.01 0.97, 1.05 0.735 1.01 0.97, 1.05 0.742
Anion gap on  admission*,b 1.02 1.01, 1.05 0.043 1.02 1.00, 1.05 0.050
Percentage parasitaemia on admission (%)b 1.03 1.01, 1.06 0.008 1.03 1.01, 1.06 0.014
Respiratory rate on admission (cycles/minute) 0.98 0.95, 1.02 0.344 0.98 0.95, 1.02 0.328
Respiratory distress on  admissionb Yes 3.62 1.69, 7.76 0.013 3.62 1.64, 8.02 0.002
No 1.00 1.00
Somers’  Da 0.52 0.49
Fig. 1 Receiver operating characteristic cure showing diagnostic 
accuracy of model to predict development of sepsis during 
admission for severe malaria
Fig. 2 Graph showing a plot of the expected event probabilities 
against the predicted event probabilities with a perfect predictive 
ability shown on the graph by the diagonal red straight line at 45°
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showing that although respiratory distress was com-
mon in malaria, it was more prominent in patients with 
a concomitant sepsis [18]. In African children with severe 
malaria, both Streptococcus pneumoniae/Haemophilus 
influenzae (causing mainly pneumonia) were shown to be 
a common cause of concomitant sepsis [5].
Metabolic acidosis in severe malaria mainly results 
from microvascular obstruction by infected erythrocytes 
compromising tissue perfusion, including in vital organs 
such as brain and kidney [19, 20], another complication 
found to be an independent predictor of development 
of sepsis in this study. Renal failure in sepsis involves 
immune-mediated microvascular and tubular dysfunc-
tion. Although the pathogenesis is different, metabolic 
acidosis and renal failure are also common complications 
in patients with severe sepsis [20, 21]. This could explain 
why acidosis and renal failure symptoms were predictive 
of concomitant sepsis in this analysis. Non-Salmonella 
Table 4 Numerical contributions of categories of predictors to development of sepsis
Predictor Percentage contribution 
of predictor (%)
Categories of predictor Numerical 
contribution
1 Jaundice on admission 6.4 Yes 3.1
No 0.0
2 Anion gap on admission 18.9 < − 30 0.0
> − 30.0 to − 20.2 1.0
> − 20.2 to − 10.4 2.0


















3 Sex 9.3 Male 0.0
Female 4.5
4 Coma on admission 7.7 Yes 3.7
No 0.0
4 Shock on admission 11.8 Yes 5.7
No 0.0
5 Respiratory distress on admission 12.0 Yes 5.8
No 0.0






7 Total possible score 100.0 – 48.2
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typhi and gram negative bacteria (both gut bacteria) are 
known causes of sepsis in malaria [5]. It has been hypoth-
esized that increased translocation of bacteria from the 
gut caused by the sequestration of parasitized red blood 
cells in the gut microcirculation are a causative factor [6, 
22]. The latter is a function of the total parasite burden as 
are plasma PfHRP2 concentrations. This could thus link 
acidosis and high percentage of parasitaemia to the inci-
dence of sepsis in malaria.
All four predictors: metabolic acidosis (measured as 
an increased anion gap), parasite burden (high para-
sitaemia), renal failure (measured as BUN levels) and 
hypotensive shock (by taking the blood pressure) are all 
parameters which can be used in resource-limited set-
tings where laboratory facilities have been supplemented. 
The presented model could thus be beneficial in the field 
setting and aid clinicians to identify patients at risk for 
developing bacterial sepsis.
The AUC of the model (0.78) was similar to that of the 
validated bootstrapped AUC (0.78). The model fell within 
the range of fair discriminative properties (0.70–0.80). 
This was further confirmed using the Brier score and the 
Somers’ D. The Brier score from this model (0.06) is close 
to zero indicating that the model can distinguish between 
those who will not and those who will develop sepsis. The 
optimism corrected estimate of the Somers’ D obtained 
after bootstrapping (0.49) produced a c-statistic (0.74), 
which falls in the range of fair discriminative properties. 
The model was also properly calibrated as demonstrated 
in the calibration plot. There was no difference between 
the observed and predicted values for patients who 
developed sepsis.
Table 5 Diagnostic properties of model at various cut-off values of the total score
PS predicted with sepsis, PNS predicted with no sepsis, PPV positive predictive value, NPV negative predictive value, OCCR overall correct classification rate, Prob 
probability
Cut-off Total score Prob (%) Sepsis No sepsis Sensitivity Specificity PPV NPV OCCR 
PS PNS PS PNS
25th percentile 14.6 7.0 56 24 295 670 70.00 69.43 15.95 96.54 69.47
Median 18.8 18 31 49 63 902 38.75 93.47 32.98 94.85 89.28
75th percentile 23.2 31 15 65 21 944 18.75 97.82 41.67 93.56 91.77
Fig. 3 Nomogram showing the relative contributions of independent predictors to the development of sepsis of sepsis during admission for severe 
malaria
Page 9 of 10Njim et al. Malar J  (2018) 17:278 
Sepsis occurring in severe malaria is associated with 
an increased risk of mortality. A good model should 
have a reasonably high sensitivity to include a high num-
ber of individuals at risk of having the outcome. In this 
study, using a 7.0% probability had the highest sensitivity 
(70.0%). Though this sensitivity is modest, this prognostic 
model shows potential for predicting the development of 
sepsis in adult patients with severe malaria.
Nadjm et al. [10] produced a model to predict the risk 
of development of sepsis in severe malaria in 2010 lim-
ited to paediatric cases. This model had a high sensitiv-
ity (86%) but a low specificity (22.3%) [10]. The model 
also included several WHO criteria which were based on 
nonspecific symptoms limiting its application in clinical 
settings. One of the variables included in their research 
was the presence of HIV infection. HIV status was not 
assessed in the current study, but prevalence rate in this 
patient group was considered to be low. However, inclu-
sion of this variable in future research may help improve 
the sensitivity of the model.
Limitations
A limitation of the current study is that the clinical diag-
nosis for sepsis is not very accurate. Therefore, the study 
findings will have to be confirmed in future studies using 
more accurate diagnostic tools for diagnosing sepsis, 
including blood cultures or molecular methods. Blood 
cultures are usually considered to be the clinical gold 
standard for the diagnosis of sepsis, but their sensitivity 
is limited [23]. In addition, studies in different geographi-
cal regions with different epidemiological settings should 
confirm the generalizability of this study findings.
Conclusions
The development of sepsis is relatively common in adults 
admitted with severe falciparum malaria. The identified 
prognosticators from the presented model identified 
patients with severe malaria at higher risk of develop-
ing clinical sepsis, potentially benefiting from antibiotic 
treatment in addition to anti-malarials. The model needs 
further evaluation with more strictly defined bacterial 
sepsis as outcome measure.
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